A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases.

Biofunctional matrices for in vivo tissue engineering strategies must be modifiable in both biomolecular composition and mechanical characteristics. To address this challenge, we present a modular system of biohybrid hydrogels based on covalently cross-linked heparin and star-shaped poly(ethylene glycols) (star-PEG) in which network characteristics can be gradually varied while heparin contents remain constant. Mesh size, swelling and elastic moduli were shown to correlate well with the degree of gel component cross-linking. Additionally, secondary conversion of heparin within the biohybrid gels allowed the covalent attachment of cell adhesion mediating RGD peptides and the non-covalent binding of soluble mitogens such as FGF-2. We applied the biohybrid gels to demonstrate the impact of mechanical and biomolecular cues on primary nerve cells and neural stem cells. The results demonstrate the cell type-specific interplay of synergistic signaling events and the potential of biohybrid materials to selectively stimulate cell fate decisions. These findings suggest important future uses for this material in cell replacement based-therapies for neurodegenerative diseases.

[1]  Johannes Schwarz,et al.  Low atmospheric oxygen avoids maturation, senescence and cell death of murine mesencephalic neural precursors , 2005, Journal of neurochemistry.

[2]  P. Janmey,et al.  Tissue Cells Feel and Respond to the Stiffness of Their Substrate , 2005, Science.

[3]  Kristi S. Anseth,et al.  PEG Hydrogels for the Controlled Release of Biomolecules in Regenerative Medicine , 2009, Pharmaceutical Research.

[4]  Wim E Hennink,et al.  Biodegradable dextran hydrogels for protein delivery applications , 2007, Expert review of medical devices.

[5]  K. Anseth,et al.  Contrasting effects of collagen and bFGF-2 on neural cell function in degradable synthetic PEG hydrogels. , 2007, Journal of biomedical materials research. Part A.

[6]  Kwang-Soo Kim,et al.  Genetic selection of sox1GFP‐expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation , 2006, Journal of neurochemistry.

[7]  Y. Katsube,et al.  Crystal structure of basic fibroblast growth factor at 1.6 A resolution. , 1994, Journal of biochemistry.

[8]  M. Horne,et al.  Neural tissue engineering of the CNS using hydrogels. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.

[9]  Christine E Schmidt,et al.  Neural tissue engineering: strategies for repair and regeneration. , 2003, Annual review of biomedical engineering.

[10]  A. Khademhosseini,et al.  Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology , 2006 .

[11]  C. Werner,et al.  Maleic anhydride copolymers--a versatile platform for molecular biosurface engineering. , 2003, Biomacromolecules.

[12]  Elisabet Englund,et al.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.

[13]  P. Brundin,et al.  Immune reactions following systemic immunization prior or subsequent to intrastriatal transplantation of allogeneic mesencephalic tissue in adult rats , 1995, Neuroscience.

[14]  V. Simplaceanu,et al.  Tissue water content and nuclear magnetic resonance in normal and tumor tissues. , 1975, Cancer research.

[15]  A. Storch,et al.  Transplantation of human neural precursor cells in the 6-OHDA lesioned rats: effect of immunosuppression with cyclosporine A. , 2006, Parkinsonism & related disorders.

[16]  H. Hall.  Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis. , 2007, Current pharmaceutical design.

[17]  X Huang,et al.  On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[18]  J. Hubbell,et al.  Covalently conjugated VEGF--fibrin matrices for endothelialization. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Johannes Schwarz,et al.  Neurorestoration in Parkinson’s disease by cell replacement and endogenous regeneration , 2004, Expert opinion on biological therapy.

[20]  K. Anseth,et al.  Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. , 2005, Acta biomaterialia.

[21]  Krista L. Niece,et al.  Selective Differentiation of Neural Progenitor Cells by High-Epitope Density Nanofibers , 2004, Science.

[22]  D. Mooney,et al.  Hydrogels for tissue engineering: scaffold design variables and applications. , 2003, Biomaterials.

[23]  K. Fabel,et al.  Rostro‐Caudal Gradual Loss of Cellular Diversity Within the Periventricular Regions of the Ventricular System , 2009, Stem cells.

[24]  J. Hubbell,et al.  Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. , 2005, Biophysical journal.

[25]  Tetsuya Suhara,et al.  Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor , 2007, Brain Research.

[26]  J. Hubbell,et al.  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.

[27]  C. Werner,et al.  Quantitative analysis of immobilized proteins and protein mixtures by amino acid analysis. , 2003, Journal of chromatography. A.

[28]  J. Hubbell,et al.  The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. , 2008, Biomaterials.

[29]  Albert J. Keung,et al.  Substrate modulus directs neural stem cell behavior. , 2008, Biophysical journal.

[30]  E. Furst,et al.  Growth factor mediated assembly of cell receptor-responsive hydrogels. , 2007, Journal of the American Chemical Society.

[31]  A. Hoffman,et al.  PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor , 2006, Journal of biomaterials science. Polymer edition.

[32]  Johannes Schwarz,et al.  Long-Term Proliferation and Dopaminergic Differentiation of Human Mesencephalic Neural Precursor Cells , 2001, Experimental Neurology.

[33]  J. Hubbell,et al.  Development of fibrin derivatives for controlled release of heparin-binding growth factors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Christopher S. Chen,et al.  Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. , 2004, Developmental cell.

[35]  Xinqiao Jia,et al.  Hybrid multicomponent hydrogels for tissue engineering. , 2009, Macromolecular bioscience.

[36]  E. Clarkson,et al.  Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats , 1998, Brain Research.

[37]  R. Gilbert,et al.  Agarose and methylcellulose hydrogel blends for nerve regeneration applications , 2008, Journal of neural engineering.

[38]  Nic D. Leipzig,et al.  The effect of immobilized platelet derived growth factor AA on neural stem/progenitor cell differentiation on cell-adhesive hydrogels. , 2008, Biomaterials.

[39]  C. Werner.  Polymers for Regenerative Medicine , 2010 .

[40]  Yasuo Suzuki,et al.  Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release. , 2003, Journal of biomedical materials research. Part A.

[41]  Glenn D Prestwich,et al.  Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. , 2005, Biomaterials.

[42]  K. Anseth,et al.  The effect of heparin-functionalized PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic differentiation. , 2007, Biomaterials.

[43]  Kristi L Kiick,et al.  Rheological characterization of polysaccharide-poly(ethylene glycol) star copolymer hydrogels. , 2005, Biomacromolecules.

[44]  A. Panitch,et al.  Physical polymer matrices based on affinity interactions between peptides and polysaccharides. , 2003, Biomacromolecules.

[45]  Sarah C. Heilshorn,et al.  Independent tuning of multiple biomaterial properties using protein engineering , 2009 .

[46]  Aaron D Baldwin,et al.  Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[47]  Dietmar W Hutmacher,et al.  Scaffold-based bone engineering by using genetically modified cells. , 2005, Gene.

[48]  R. Hauser,et al.  Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.

[49]  M. Gerlach,et al.  Multipotent Neural Stem Cells from the Adult Tegmentum with Dopaminergic Potential Develop Essential Properties of Functional Neurons , 2006, Stem cells.

[50]  H. Lester,et al.  Functional characterization of dopaminergic neurons derived from rodent mesencephalic progenitor cells , 2003, Journal of Chemical Neuroanatomy.

[51]  Erin B Lavik,et al.  A library of tunable poly(ethylene glycol)/poly(L-lysine) hydrogels to investigate the material cues that influence neural stem cell differentiation. , 2009, Journal of biomedical materials research. Part A.

[52]  Melinda Larsen,et al.  Extracellular matrix dynamics in development and regenerative medicine , 2008, Journal of Cell Science.

[53]  A A Poot,et al.  Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[54]  V. Bloomfield.  The structure of bovine serum albumin at low pH. , 1966, Biochemistry.

[55]  M R Thompson,et al.  Hydrodynamic structure of bovine serum albumin determined by transient electric birefringence. , 1975, Biophysical journal.

[56]  Robert J. Linhardt,et al.  Heparin—Protein Interactions , 2002 .

[57]  A. Ludolph,et al.  Protective Effects of Riluzole on Dopamine Neurons , 2000, Journal of neurochemistry.

[58]  David A Tirrell,et al.  Protein engineering approaches to biomaterials design. , 2005, Current opinion in biotechnology.

[59]  J. Tessmar,et al.  Customized PEG-derived copolymers for tissue-engineering applications. , 2007, Macromolecular bioscience.

[60]  O. Hansson,et al.  Patterns of Cell Death and Dopaminergic Neuron Survival in Intrastriatal Nigral Grafts , 1999, Experimental Neurology.

[61]  Linshu Liu,et al.  Hyaluronate-heparin conjugate gels for the delivery of basic fibroblast growth factor (FGF-2). , 2002, Journal of biomedical materials research.

[62]  P. Janmey,et al.  Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. , 2005, Cell motility and the cytoskeleton.

[63]  Shingo Nakamura,et al.  Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization. , 2006, Journal of biomedical materials research. Part A.

[64]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[65]  S. Goderie,et al.  FGF2 Concentration Regulates the Generation of Neurons and Glia from Multipotent Cortical Stem Cells , 1997, Neuron.